Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
2010
Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers
2008
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
1998
Post-cholecystectomy symptoms after laparoscopic cholecystectomy.
1993
Is cholecystectomy effective treatment for symptomatic gallstones? Clinical outcome after long-term follow-up.
1998
Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study
2002
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
2011
Outcome after cholecystectomy for symptomatic gall stone disease and effect of surgical access: laparoscopic v open approach.
1993
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
2008
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care
2007
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Neuroticism in Relation to Recovery and Persisting Pain after Laparoscopic Cholecystectomy
1998
Pain and Dyspepsia after Elective and Acute Cholecystectomy
1998
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
2012
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
2011 StandoutNobel
Neoadjuvant Therapy in the Treatment of Breast Cancer
2014
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer
2000
Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey
2009 Standout
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
1995
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
2001
Targeting hypoxia in cancer therapy
2011 Standout
Personalized treatment of early-stage breast cancer: Present concepts and future directions
2010
Breast cancer
2016 Standout
Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
2008
Human Genetics Shape the Gut Microbiome
2014 Standout
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Translating cancer research into targeted therapeutics
2010 Nature
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Epidermal Growth Factor Receptor Targeting in Cancer
2006
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
2012
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
2007
Is There a Use for Tailored Print Communications in Cancer Risk Communication?
1999
Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
2010
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
2002
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
Antibody therapy of cancer
2012 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer
2010
Pathological prognostic factors in breast cancer
1999 Standout
What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature
1995
The cancer biomarker problem
2008 Nature
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Predictors of uptake of obesity genetic testing among affected adults
2006
Blast Injuries
2005 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Loss-of-Function Mutation in the Dioxygenase-Encoding FTO Gene Causes Severe Growth Retardation and Multiple Malformations
2009 StandoutNobel
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Risk of early recurrence among postmenopausal women with estrogen receptor‐positive early breast cancer treated with adjuvant tamoxifen
2008
Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions.
2007 Standout
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
2010
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
MANAGEMENT OF UNIQUE CLINICAL ENTITIES IN DISASTER MEDICINE
1996
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Biological determinants of endocrine resistance in breast cancer
2009
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
Axillary lymph nodes and breast cancer. A review
1995
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Breast cancer metastasis: markers and models
2005 Standout
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
HEALTH PSYCHOLOGY: Mapping Biobehavioral Contributions to Health and Illness
1999
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
1999
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
2006
Patient Understanding of Genetic Principles and Their Expectations of Genetic Services within the NHS: A Qualitative Study
1998
Decision aids for people facing health treatment or screening decisions
2017 Standout
Evaluating patient-based outcome measures for use in clinical trials.
1998
Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
2007
Breast Cancer Treatment
2019 Standout
Surgical treatment of primary breast cancer in the neoadjuvant setting
2014
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Evaluation of Treatment-Effect Heterogeneity Using Biomarkers Measured on a Continuous Scale: Subpopulation Treatment Effect Pattern Plot
2010
A New Initiative on Precision Medicine
2015 Standout
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
2008
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Quality-of-Life Assessment: Can We Keep It Simple?
1992
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells
2005
Symptomatic outcome 1 year after laparoscopic and minilaparotomy cholecystectomy: A randomized trial
1995
Long-term results after laparoscopic cholecystectomy
1995
Symptomatic outcome after laparoscopic cholecystectomy
1993
Chronic Pain as an Outcome of Surgery
2000 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
1996
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Primary Systemic Therapy of Breast Cancer
2006
Works of S. Ebbs being referenced
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer
2003
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)
2005
The Purley train crash: procedural difficulties.
1992
Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling
1996
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer
1999
Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer
2007
Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer
1999
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in theneo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial
2004
Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen
1996
Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer
1992
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
1998
High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.
1995
Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial
2005
Influence of cholecystectomy on symptoms
1991
Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.
1993
Treatment Outcomes and Quality of Life
1989
Assessment of breast cancer size: a comparison of methods.
1992
Is Surgery Necessary After Complete Clinical Remission Following Neoadjuvant Chemotherapy for Early Breast Cancer?
2003
Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer
1993